Gerresheimer AG: Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite ...
Organic growth: revenue +2.9%, adjusted EBITDA +4.1%Destocking in vial business partially offset by strong growth in medical devicesGrowth strategy execution: capacity expansions and higher revenue sh ...
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Organic growth: revenue +2.9%, adjusted EBITDA +4.1% Destocking in vial business partially offset by strong growth in medical ...